Title: Noncash Assistance
Accounting Policies: The consolidated financial statements contained in Stamford Health, Inc. and subsidiaries (Stamford Health) annual audit report are prepared on the accrual basis of accounting. Refer to the notes of the consolidated financial statements for a summary of the significant accounting policies.The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the Federal grant activity of Stamford Health and is reported on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements of Stamford Health.For purposes of the Schedule, federal awards include any assistance provided by a federal agency directly or indirectly in the form of grants, contracts, cooperative agreements, loan and loan guarantees, or other non-cash assistance.Direct and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX and 45 CFR Part 75 Appendix E, as applicable. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement.
De Minimis Rate Used: N
Rate Explanation: The Uniform Guidance provides for a 10% de minimis indirect cost rate election; however, Stamford Health, Inc. did not make this election and uses a negotiated indirect cost rate.
During the year ended September 30, 2022, the U.S. Department of Health and Human Services issued $19,689 in federally funded vaccines to Stamford Health through the Immunization Cooperative Agreements program (Assistance Listing No. 93.268). This non-cash assistance, which was passed through the State of Connecticut Department Health, is included in the accompanying Schedule.
Title: COVID-19 - Provider Relief Fund
Accounting Policies: The consolidated financial statements contained in Stamford Health, Inc. and subsidiaries (Stamford Health) annual audit report are prepared on the accrual basis of accounting. Refer to the notes of the consolidated financial statements for a summary of the significant accounting policies.The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the Federal grant activity of Stamford Health and is reported on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements of Stamford Health.For purposes of the Schedule, federal awards include any assistance provided by a federal agency directly or indirectly in the form of grants, contracts, cooperative agreements, loan and loan guarantees, or other non-cash assistance.Direct and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX and 45 CFR Part 75 Appendix E, as applicable. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement.
De Minimis Rate Used: N
Rate Explanation: The Uniform Guidance provides for a 10% de minimis indirect cost rate election; however, Stamford Health, Inc. did not make this election and uses a negotiated indirect cost rate.
In accordance with the U.S. Department of Health and Human Services requirements specific to Federal Assistance Listing No. 93.498, COVID-19 Provider Relief Fund, the amount presented on the accompanying Schedule for the year ended September 30, 2022 for Federal Assistance Listing No. 93.498 relates to (i) Provider Relief Fund (PRF) payments received from July 1, 2020 through June 30, 2021 (ii) used for PRF-eligible activity from the period January 1, 2020 through June 30, 2022. This payment receipt period and activity period and the resulting amount presented on the accompanying Schedule for the year ended September 30, 2022 reconciles to the PRF information previously reported to the Health Resources and Services Administration (HRSA) for PRF Reporting Periods 2 as follows (see the Notes to the SEFA for the chart). The expenses attributable to Coronavirus Disease 2019 (COVID-19) and lost revenues incurred by Stamford Health during the period of availability for PRF Reporting Period 2 (January 1, 2020 through December 31, 2021) are in excess of the distributions received from July 1, 2020 through December 31, 2020 and, therefore, the amounts presented in the chart included in the Notes to the SEFA and on the accompanying Schedule are limited to the amount of such distributions. Stamford Health did not receive PRF payments in PRF Reporting Period 3 (January 1, 2021 to June 30, 2021).